[Validation and clinical application of MammaPrint( ®) in patients with breast cancer].

CONCLUSION: MammaPrint(®) is an effective study to determine risk of recurrence of in early stage breast cancer.
PMID: 27979362 [PubMed - as supplied by publisher]

Source: Cirugia y Cirujanos - December 11, 2016 Category: Surgery Authors: Sánchez-Forgach ER, Carpinteyro-Espín U, Alemán-Áviles JA, Sánchez-Basurto C Tags: Cir Cir Source Type: research